Literature DB >> 24387121

Two cases of acute respiratory distress syndrome resulting from adult-onset Still's disease.

H Hagiyama1, R Koike, K Nagasaka, Y Nonomura, J Nishio, T Nanki, H Kohsaka, T Kubota, N Miyasaka.   

Abstract

Abstract Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown origin. Acute respiratory distress syndrome (ARDS) is a rare complication of AOSD, with only nine cases having been reported in the literature. Here, we describe two cases of AOSD complicated with ARDS that were successfully treated with immunosuppressive therapy, including corticosteroids. Although ARDS is a life-threatening complication in AOSD, early commencement of high-dose corticosteroids and mechanical ventilation improve the prognosis.

Entities:  

Year:  2003        PMID: 24387121     DOI: 10.3109/s101650300012

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

1.  Adult onset Still's disease accompanied by acute respiratory distress syndrome: A case report.

Authors:  Xiao-Tu Xi; Mao-Jie Wang; Run-Yue Huang; Bang-Han Ding
Journal:  Exp Ther Med       Date:  2016-07-11       Impact factor: 2.447

2.  Adult Onset Still's Disease Presenting with Acute Respiratory Distress Syndrome: Case Report and Review of the Literature.

Authors:  Anisha B Dua; Augustine M Manadan; John P Case
Journal:  Open Rheumatol J       Date:  2013-12-30

Review 3.  Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.

Authors:  Mathieu Gerfaud-Valentin; Vincent Cottin; Yvan Jamilloux; Arnaud Hot; Agathe Gaillard-Coadon; Isabelle Durieu; Christiane Broussolle; Jean Iwaz; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

4.  Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease.

Authors:  Grant H Lowther; Jason Chertoff; Jessica Cope; Hassan Alnuaimat; Ali Ataya
Journal:  Pulm Circ       Date:  2017-06-06       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.